Antony, France

Anne Coutel

This inventor holds 2 USPTO granted patents. Top assignee: Farmalyoc. Active years: 1995.


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 104(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Anne Coutel: Innovator in Pharmaceutical Formulations

Introduction

Anne Coutel is a prominent inventor based in Antony, France. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative dosage forms. With a total of 2 patents to her name, her work focuses on enhancing the delivery of therapeutically active substances.

Latest Patents

Anne Coutel's latest patents include a solid and porous single dosage form comprising particles. This invention relates to new solid and porous single dosage forms that include beads and their preparation. Another notable patent is for a solid porous unitary form comprising micro-particles and/or nano-particles, which are made by lyophilization. These formulations are useful for the administration of therapeutic agents, nutritional agents, diagnostic agents, or cosmetic agents.

Career Highlights

Throughout her career, Anne has been associated with Farmalyoc, where she has played a crucial role in advancing pharmaceutical technologies. Her innovative approaches have positioned her as a key figure in the industry, contributing to the development of effective and efficient drug delivery systems.

Collaborations

Anne Coutel has collaborated with notable professionals in her field, including Guy Lebreton and Michel Veillard. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Anne Coutel's contributions to pharmaceutical formulations demonstrate her commitment to innovation and excellence in the field. Her patents reflect her dedication to improving drug delivery systems, making her a valuable asset to the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…